Christopher J. Williams - 30 Dec 2022 Form 4 Insider Report for CLOROX CO /DE/ (CLX)

Role
Director
Signature
By Cheryl Brice, Attorney-in-Fact for
Issuer symbol
CLX
Transactions as of
30 Dec 2022
Net transactions value
$0
Form type
4
Filing time
04 Jan 2023, 16:12:57 UTC
Previous filing
01 Nov 2022
Next filing
04 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLX Deferred Stock Units Award $0 +105 +0.82% $0.000000 12,965 10 Nov 2022 Common Stock 105 Direct F1, F2, F3
transaction CLX Deferred Stock Units Award $0 +1,073 +8.3% $0.000000 14,038 30 Dec 2022 Common Stock 1,073 Direct F1, F3, F4
transaction CLX Deferred Stock Units Award $0 +228 +1.6% $0.000000 14,267 30 Dec 2022 Common Stock 228 Direct F1, F3, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1-for-1
F2 Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.
F3 The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.
F4 Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan.
F5 Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees.